Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Baum

Showing results (101-110 of 191) with videos related to

Pageof 20
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 21, 2002
The future of breast cancer research in dangerMichael Baum, Mary Buchanan, Jose Baselga, et al.
Molecular Genetics and Genomics : MGG|October 14, 2006
Transcriptional analysis between two wheat near-isogenic lines contrasting in aluminum tolerance under aluminum stressPeiguo Guo, Guihua Bai, Brett Carver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status: an hypothesis-generating studyMitch Dowsett, Jack Cuzick, Chris Wale, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 9, 2002
The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancerJayant S Vaidya, Michael Baum, Jeffrey S Tobias, et al.
Lancet (London, England)|August 29, 2006
Bradford NHS trust and PanoramaMichel P Coleman, Bernard Rachet, Manuela Quaresma, et al.
Lancet (London, England)|January 12, 2018
Targeted radiotherapy for early breast cancerJayant S Vaidya, Max Bulsara, Frederik Wenz, et al.
Plos One|October 1, 2019
Multi-dimensional evaluation of response to salt stress in wheatSaid Dadshani, Ram C Sharma, Michael Baum, et al.
The Lancet. Oncology|December 18, 2007
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial, John F Forbes, Jack Cuzick, et al.
Lancet (London, England)|April 27, 2016
Partial breast irradiation and the GEC-ESTRO trialJayant S Vaidya, Max Bulsara, Frederik Wenz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Long-term benefits of 5 years of tamoxifen: 10-year follow-up of a large randomized trial in women at least 50 years of age with early breast cancerAllan Hackshaw, Michael Roughton, Sharon Forsyth, et al.
Pageof 20

Showing results (101-110 of 191) with videos related to

Sort By:
Pageof 20
European Journal of Cancer (Oxford, England : 1990)|November 21, 2002
The future of breast cancer research in dangerMichael Baum, Mary Buchanan, Jose Baselga, et al.
Molecular Genetics and Genomics : MGG|October 14, 2006
Transcriptional analysis between two wheat near-isogenic lines contrasting in aluminum tolerance under aluminum stressPeiguo Guo, Guihua Bai, Brett Carver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status: an hypothesis-generating studyMitch Dowsett, Jack Cuzick, Chris Wale, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 9, 2002
The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancerJayant S Vaidya, Michael Baum, Jeffrey S Tobias, et al.
Lancet (London, England)|August 29, 2006
Bradford NHS trust and PanoramaMichel P Coleman, Bernard Rachet, Manuela Quaresma, et al.
Lancet (London, England)|January 12, 2018
Targeted radiotherapy for early breast cancerJayant S Vaidya, Max Bulsara, Frederik Wenz, et al.
Plos One|October 1, 2019
Multi-dimensional evaluation of response to salt stress in wheatSaid Dadshani, Ram C Sharma, Michael Baum, et al.
The Lancet. Oncology|December 18, 2007
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial, John F Forbes, Jack Cuzick, et al.
Lancet (London, England)|April 27, 2016
Partial breast irradiation and the GEC-ESTRO trialJayant S Vaidya, Max Bulsara, Frederik Wenz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Long-term benefits of 5 years of tamoxifen: 10-year follow-up of a large randomized trial in women at least 50 years of age with early breast cancerAllan Hackshaw, Michael Roughton, Sharon Forsyth, et al.
Pageof 20